CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Cristina Sanchez

OPENALEX: A5046720479↗ORCID: 0000-0002-1428-3078↗

Affiliations

Organizations

Biomedical Research Networking Center on Neurodegenerative Diseasesauthorship · ES Instituto Ramón y Cajal de Investigación Sanitariaauthorship · ES Research Institute Hospital 12 de Octubreauthorship · ES Universidad Complutense de Madridauthorship · ES

Public evidence

3 connected articles

Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 response.2026 · Europe PMC Neuronal Cannabinoid CB<sub>1</sub> Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.2023 · Europe PMC A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.2006 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Cristina Sanchez - Medical Cannabis Research Engine